title: Interaction of Leptospira interrogans with human proteolytic systems enhances dissemination through endothelial cells and protease levels.
abstract: We have recently reported the ability of Leptospira to capture plasminogen (PLG) and generate plasmin (PLA) bound on the microbial surface in the presence of exogenous activators. In this work, we examined the effects of leptospiral PLG binding for active penetration through the endothelial cell barrier and activation. The results indicate that leptospires with PLG association or PLA activation have enhanced migration activity through human umbilical vein endothelial cell (HUVEC) monolayers compared with untreated bacteria. Leptospira cells coated with PLG were capable of stimulating the expression of PLG activators by HUVECs. Moreover, leptospires endowed with PLG or PLA promoted transcriptional upregulation matrix metalloprotease 9 (MMP-9). Serum samples from patients with confirmed leptospirosis showed higher levels of PLG activators and total MMP-9 than serum samples from normal (healthy) subjects. The highest level of PLG activators and total MMP-9 was detected with microscopic agglutination test (MAT)-negative serum samples, suggesting that this proteolytic activity stimulation occurs at the early stage of the disease. Furthermore, a gelatin zymography profile obtained for MMPs with serum samples from patients with leptospirosis appears to be specific to leptospiral infection because serum samples from patients with unrelated infectious diseases produced no similar degradation bands. Altogether, the data suggest that the Leptospira-associated PLG or PLA might represent a mechanism that contributes to bacterial penetration of endothelial cells through an activation cascade of events that enhances the proteolytic capability of the organism. To our knowledge, this is the first proteolytic activity associated with leptospiral pathogenesis described to date.
authors.affiliation: Centro de Biotecnologia, Instituto Butantan, São Paulo, SP, Brazil.
authors.forename: Monica L
authors.initials: ML
authors.lastname: Vieira
authors.forename: Miryam P
authors.initials: MP
authors.lastname: Alvarez-Flores
authors.forename: Karin
authors.initials: K
authors.lastname: Kirchgatter
authors.forename: Eliete C
authors.initials: EC
authors.lastname: Romero
authors.forename: Ivy J
authors.initials: IJ
authors.lastname: Alves
authors.forename: Zenaide M
authors.initials: ZM
authors.lastname: de Morais
authors.forename: Silvio A
authors.initials: SA
authors.lastname: Vasconcellos
authors.forename: Ana M
authors.initials: AM
authors.lastname: Chudzinski-Tavassi
authors.forename: Ana L T O
authors.initials: AL
authors.lastname: Nascimento
mesh_terms: D042783:Endothelial Cells / Q000201:enzymology*; D004797:Enzyme-Linked Immunosorbent Assay; D005341:Fibrinolysin / Q000378:metabolism; D054884:Host-Pathogen Interactions; D006801:Humans; D007921:Leptospira interrogans / Q000378:metabolism / Q000472:pathogenicity*; D007922:Leptospirosis / Q000201:enzymology* / Q000378:metabolism; D020778:Matrix Metalloproteinase 2 / Q000378:metabolism*; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism*; D010958:Plasminogen / Q000378:metabolism; D010960:Plasminogen Activators / Q000097:blood; D059748:Proteolysis; D014471:Umbilical Veins / Q000166:cytology
chemical_list: D010958:Plasminogen; D010960:Plasminogen Activators; D005341:Fibrinolysin; D020778:Matrix Metalloproteinase 2; D020780:Matrix Metalloproteinase 9